Golden House Ltd (TLV:GOHO)
1,277.00
+50.00 (4.07%)
May 29, 2025, 5:24 PM IDT
Golden House Revenue
Golden House had revenue of 11.26M ILS in the quarter ending March 31, 2025, with 14.85% growth. This brings the company's revenue in the last twelve months to 41.28M, down -27.80% year-over-year. In the year 2024, Golden House had annual revenue of 39.82M, down -26.66%.
Revenue (ttm)
41.28M
Revenue Growth
-27.80%
P/S Ratio
4.78
Revenue / Employee
355.83K
Employees
116
Market Cap
197.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 39.82M | -14.48M | -26.66% |
Dec 31, 2023 | 54.30M | -1.68M | -3.00% |
Dec 31, 2022 | 55.97M | -237.00K | -0.42% |
Dec 31, 2021 | 56.21M | -3.80M | -6.33% |
Dec 31, 2020 | 60.01M | 3.40M | 6.01% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 61.87B |
Danel (Adir Yeoshua) | 2.81B |
Kamada | 622.70M |
Bait Bakfar | 104.50M |
SofWave Medical | 235.09M |
BrainsWay | 161.81M |
Novolog (Pharm-Up 1966) | 2.07B |
Ilex Medical | 920.37M |